Oncologix Tech (OCLG) Stock Overview

A diversified medical holding company, provides health care services in the United States. More details

OCLG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($166K)

Latest financial reports are more than a year old

Shares are highly illiquid

OCLG Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Oncologix Tech, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Oncologix Tech
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	-96.55%
5 Year Change	-50.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	OCLG	US Healthcare	US Market
7D	0%	-6.0%	0.8%
1Y	0%	-30.6%	13.7%

Return vs Industry: OCLG exceeded the US Healthcare industry which returned -30.6% over the past year.

Return vs Market: OCLG underperformed the US Market which returned 13.7% over the past year.

Price Volatility

Is OCLG's price volatile compared to industry and market?
OCLG volatility
OCLG Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: OCLG's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine OCLG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	n/a	Michael Kramarz	www.oclghealth.com

Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers.

Oncologix Tech, Inc. Fundamentals Summary

How do Oncologix Tech's earnings and revenue compare to its market cap?
OCLG fundamental statistics
Market cap	US$166.25k
Earnings (TTM)	-US$1.75m
Revenue (TTM)	US$4.61m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is OCLG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OCLG income statement (TTM)
Revenue	US$4.61m
Cost of Revenue	US$3.63m
Gross Profit	US$981.05k
Other Expenses	US$2.73m
Earnings	-US$1.75m

Last Reported Earnings

May 31, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did OCLG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/07/22 21:52
End of Day Share Price	2025/07/17 00:00
Earnings	2015/05/31
Annual Earnings	2014/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Oncologix Tech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.